Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disparities in cancer screening and preventive care access among LGBTQ+ populations: A cross-sectional study.

Journal of family medicine and primary care·2026

Same author

Secondary thrombotic thrombocytopenic purpura with features of Evans syndrome in a patient with SLE.

BMJ case reports·2026

Same author

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026

Same author

Sustained Correction of Hereditary Antithrombin Deficiency in Mice by AAV8-Mediated Gene Delivery.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

A data reduction workflow for mass spectrometry proteoform testing in the clinical laboratory: from antithrombin peaks to diagnosis.

Clinical chemistry and laboratory medicine·2026

Same author

CRE26-069: Human Herpesvirus-8 Associated Multicentric Castleman Disease Presenting as Secondary Hemophagocytic Lymphohistiocytosis in Human Immunodeficiency Virus Infection.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Search research articles

Related Experiment Video

Updated: May 23, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Inherited thrombophilic conditions.

Javier Corral¹, Vicente Vicente

¹Centro Regional de Hemodonación, University of Murcia, Ronda de Garay S/N. Murcia 30003, Spain. javier.corral@carm.es

Hematology (Amsterdam, Netherlands)

|April 18, 2012

Summary

Thrombophilia research has evolved from single gene defects to complex polygenic disorders. Current thrombophilia testing requires careful evaluation of clinical relevance versus research applications for inherited conditions.

Area of Science:

Hematology
Genetics
Clinical Medicine

Background:

Antithrombin deficiency, identified in 1965, marked the beginning of understanding congenital thrombophilia.
Thrombosis is now recognized as a complex, polygenic disorder influenced by numerous genetic and acquired factors.

Purpose of the Study:

To critically evaluate the current state of thrombophilia research and clinical application.
To differentiate between the clinical utility and research potential of inherited thrombophilic conditions.

Main Methods:

Review of historical and current methodologies in thrombophilia analysis.
Analysis of the evolution from monogenic to polygenic models of thrombosis.

Main Results:

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Related Experiment Videos

Last Updated: May 23, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Significant advancements in thrombophilia testing methods, from simple assays to complex technologies.

A shift in understanding thrombosis as a multifactorial condition.

Conclusions:

Thrombophilic tests may not always have direct clinical relevance for individual risk assessment.
It is crucial to moderate conclusions and distinguish between clinical use and research in inherited thrombophilia.